HFA Premium Access

How many patients with chronic heart failure will be eligible for LCZ696 in the community?

Congress Session

About the speaker

Doctor Pierpaolo Pellicori

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

9 more presentations in this session

Efficacy of trimetazidine on functional capacity in symptomatic patients with moderately reduced or left ventricular dysfunction and CAD: a subgroup analysis of the VASCO trial

Thumbnail

Pharmacological treatment of chronic heart failure during cardiac resynchronization therapy

Speaker: Doctor J. Laukaitiene (Kaunas, LT)

Thumbnail

Effect of levosimendan on left and right ventricular function in patients with acute and chronic heart failure: a review of echocardiographic studies

Speaker: Associate Professor M. Cameli (Siena, IT)

Thumbnail

Two drugs comparasion of bisoprolol in efficiency influence on the heart rate from a position of pharmacoeconomics

Thumbnail

The ACEi switchback study

Speaker: Doctor N. Giannetti (Montreal, CA)

Thumbnail

Access the full session

Poster Session 2 - Drug therapy, other

Speakers: Doctor P. Pellicori, Doctor J. Laukaitiene, Associate Professor M. Cameli, Doctor N. Giannetti
Thumbnail

About the event

Image

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk